Mutations in the genes of isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2) play an essential role in the development of a number of tumors (gliomas, chondroid tumors, leukemia), and are important for the diagnosis and choice of therapy [1,2,3]. Here, IDH1 is linked to glioma.